1. Home
  2. CHGG vs CNXU Comparison

CHGG vs CNXU Comparison

Compare CHGG & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chegg Inc.

CHGG

Chegg Inc.

HOLD

Current Price

$0.70

Market Cap

117.4M

Sector

Real Estate

ML Signal

HOLD

Logo Conexeu Sciences Inc. Common Stock

CNXU

Conexeu Sciences Inc. Common Stock

BUY

Current Price

$2.98

Market Cap

102.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
CHGG
CNXU
Founded
2005
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Industrial Specialties
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.4M
102.7M
IPO Year
2013
2025

Fundamental Metrics

Financial Performance
Metric
CHGG
CNXU
Price
$0.70
$2.98
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 522.8K
293.4K
Earning Date
11-03-2026
02-03-2027
Dividend Yield
N/A
N/A
EPS Growth
★ 88.15
N/A
EPS
★ N/A
N/A
Revenue
★ $376,908,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.52
$3.05
52 Week High
$1.56
$13.66

Technical Indicators

Market Signals
Indicator
CHGG
CNXU
Relative Strength Index (RSI) 48.79 38.57
Support Level $0.68 $3.05
Resistance Level $0.79 $5.47
Average True Range (ATR) 0.05 0.50
MACD 0.01 0.10
Stochastic Oscillator 64.63 10.69

Price Performance

Historical Comparison
CHGG
CNXU

About CHGG Chegg Inc.

Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Chegg Skilling; and Academic Services, which derives maximum revenue. Geographically, it derives in United States and International.

About CNXU Conexeu Sciences Inc. Common Stock

Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.

Share on Social Networks: